Page last updated: 2024-08-23

dobutamine and acipimox

dobutamine has been researched along with acipimox in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bax, JJ; Cornel, JH; Fioretti, PM; Krenning, EP; Poldermans, D; Rambaldi, R; Valkema, R; van Lingen, A; Visser, FC	1
Brouwer, EM; Saris, WH; Schiffelers, SL; van Baak, MA	1
Hesselink, MK; Hoeks, J; Hul, GB; Saris, WH; Schrauwen, P; van Baak, MA; Vidal, H	1

Reviews

1 review(s) available for dobutamine and acipimox

Article	Year
FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echo. European heart journal, 1997, Volume: 18 Suppl D Topics: Cardiotonic Agents; Deoxyglucose; Dobutamine; Echocardiography; Exercise Test; Fluorodeoxyglucose F18; Glucose; Humans; Hypolipidemic Agents; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Predictive Value of Tests; Pyrazines; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	1997

Article

Year

FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echo.

European heart journal, 1997, Volume: 18 Suppl D

Topics: Cardiotonic Agents; Deoxyglucose; Dobutamine; Echocardiography; Exercise Test; Fluorodeoxyglucose F18; Glucose; Humans; Hypolipidemic Agents; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Predictive Value of Tests; Pyrazines; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

1997

Trials

1 trial(s) available for dobutamine and acipimox

Article	Year
Effect of beta1- and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans. American journal of physiology. Endocrinology and metabolism, 2003, Volume: 285, Issue:4 Topics: Adult; Albuterol; Carrier Proteins; Dobutamine; Dose-Response Relationship, Drug; Energy Metabolism; Fats; Fatty Acids, Nonesterified; Glucose; Humans; Ion Channels; Male; Mitochondrial Proteins; Muscle, Skeletal; Oxygen Consumption; Pyrazines; Receptors, Adrenergic, beta; Thigh; Uncoupling Protein 3	2003

Article

Year

Effect of beta1- and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans.

American journal of physiology. Endocrinology and metabolism, 2003, Volume: 285, Issue:4

Topics: Adult; Albuterol; Carrier Proteins; Dobutamine; Dose-Response Relationship, Drug; Energy Metabolism; Fats; Fatty Acids, Nonesterified; Glucose; Humans; Ion Channels; Male; Mitochondrial Proteins; Muscle, Skeletal; Oxygen Consumption; Pyrazines; Receptors, Adrenergic, beta; Thigh; Uncoupling Protein 3

2003

Other Studies

1 other study(ies) available for dobutamine and acipimox

Article	Year
Inhibition of lipolysis reduces beta1-adrenoceptor-mediated thermogenesis in man. Metabolism: clinical and experimental, 1998, Volume: 47, Issue:12 Topics: Adrenergic beta-Agonists; Adult; Blood Chemical Analysis; Blood Pressure; Body Temperature Regulation; Carbohydrate Metabolism; Dobutamine; Energy Metabolism; Fatty Acids, Nonesterified; Glycerol; Heart Rate; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipolysis; Male; Pyrazines; Receptors, Adrenergic, beta-1; Respiration	1998

Article

Year

Inhibition of lipolysis reduces beta1-adrenoceptor-mediated thermogenesis in man.

Metabolism: clinical and experimental, 1998, Volume: 47, Issue:12

Topics: Adrenergic beta-Agonists; Adult; Blood Chemical Analysis; Blood Pressure; Body Temperature Regulation; Carbohydrate Metabolism; Dobutamine; Energy Metabolism; Fatty Acids, Nonesterified; Glycerol; Heart Rate; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipolysis; Male; Pyrazines; Receptors, Adrenergic, beta-1; Respiration

1998